Thus, it suggests that the elevated CD36 and DGAT2 levels contribute to VPA-induced liver steatosis, which is further supported by the improved lipid deposit and the decreased CD36/ DGAT2 levels after probiotics treatment. This evidence concerns the gene CD36 and Hepatic steatosis.